Publication

Pneumonia prevention: Cost-effectiveness analyses of two vaccines among refugee children aged under two years, Haemophilus influenzae type b-containing and pneumococcal conjugate vaccines, during a humanitarian emergency, Yida camp, South Sudan

Authored by:

Gargano L.M., Hajjeh R., and Cookson S.T.

Full Citation:

Gargano L.M., Hajjeh R., and Cookson S.T. 2017. Pneumonia prevention: Cost-effectiveness analyses of two vaccines among refugee children aged under two years, Haemophilus influenzae type b-containing and pneumococcal conjugate vaccines, during a humanitarian emergency, Yida camp, South Sudan. Vaccine. 35(3).

View Publication

Additional key concepts from this publication:

Vaccines are a cost-effective means to reduce the high burden of pneumonia and diarrhea suffered by children living in humanitarian crisis settings.

Key Evidence: Children living in the Yida refugee camp in South Sudan in 2013 were found to have an elevated rate of pneumonia infections likely due to malnutrition, overcrowding, and inadequate shelter. Using these data, the CDC estimated that the use of Hib and pneumococcal vaccines in children under 2 years of age in the camp would be cost-effective under all dosing scenarios evaluated. Medecines Sans Frontiers (MSF) provided medical services to this refugee camp and found delivery of these vaccines to be feasible and effective in this setting.

Vaccination is a cost-effective approach to prevent illness in high risk populations and in fragile settings.